Neurologic Disorders
12
6
7
2
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
16.7%
2 terminated out of 12 trials
50.0%
-36.5% vs benchmark
0%
0 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (12)
The Neurodevelopmental and Behavioral Phenotyping Screening Protocol
The Impact of Environmental Controls on Mental Health
Evaluation and Treatment of Neurosurgical Disorders
Real World Outcomes of Intranasal MuSE Exosomes and Stem Cells in Neurological Regenerative Therapy
Reliability and Validity of the PReFS
Characterization of High-Level Cognitive Impairments in Patients With Neuropsychiatric Disorders
Epidemiology of Sleep-Disordered Breathing in Adults
Neurologic Stem Cell Treatment Study
Natural History of Multiple Sclerosis and Its Mimickers
Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
Anakinra, A Recombinant Human IL-1 Receptor Antagonist for Neuroinflammation in HIV-1 Infection
Monitoring Everyday Life Motor Activity in Children